Tregocel®

A multi-purpose, high quality herbal formulation designed to promote immune health and relieve inflammation.

Categories:     

Package: 60 film coated tablets/bottle

Description
Ingredients
Direction
Science
Description
Benefits
  • Maintain/support immune/digestive system health/healthy cardiovascular system function
  • Maintain/support liver health
  • Anti-inflammatory/relieve inflammation
  • Maintain/support joint health/joint mobility/flexibility
  • Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis/mild joint stiffness/pain/soreness
  • Antioxidant/Reduce free radicals formed in the body
  • Helps reduce/decrease free radical damage to body cells
  • Analgesic/Anodyne/relieve pain
Ingredients
Each film coated tablet contains

Meriva® Curcuma longa Phospholipid Complex (9024160 Indena Curcuma longa extract)
containing Curcuma longa rhizome extract
equivalent to fresh Curcuma longa rhizome
standardised to contain curcuminoids

500mg
100mg
16,500mg
100mg

Extracts dry conc. equiv. to dried:

Boswellia serrata (Frankincense) gum oleoresin

500mg

Harpagophytum procumbens (Devil’s claw) tuber

500mg

Apium graveolens (Celery) seed

500mg

Zingiber officinale (Ginger) rhizome

165mg

  • Meriva® is a Registered Trademark of Indena S.p.A., Italy
  • Free from added egg, shellfish, fish products, crustacean products, peanut, yeast, gluten, artificial flavourings, sweeteners or preservatives
  • Contains lactose and soya bean products
    • Direction
    Dosage
    • Adults: 1-2 tablets daily
    • Or as directed by a healthcare professional
    Caution
    • Always read the label. Follow the directions for use
    • If symptoms persist, talk to your health professional
    • Do not take this product if allergic to any of its composition
    • Do not use if cap seal is broken
    • Keep out of reach of children

    Always read the label. This product may not be right for you. Read the label before purchase. Follow the directions for use.

    Science
    Tregocel® has been investigated in a clinical trial in Poland, which included 142 adults aged 40 years and over, to determine its efficacy as an addition to standard medications for managing mild knee osteoarthritis. Please see the published study here.
    Menu